$39.75
0.190.48%
Last update: Jul 6, 10:07 AM
Edgewise Therapeutics Inc Earnings Estimates
EWTXNASDAQ
Edgewise Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:EWTX
Edgewise Therapeutics (EWTX) is scheduled to report Q2 earnings on August 6, 2026. Analysts estimate EPS of $-0.48 and quarterly revenue of N/A.
In the most recent quarter (Q1), Edgewise Therapeutics reported EPS of $-0.46, beating estimates of $-0.49 by 0.06%. Revenue came in at $0, meeting the estimate of $0 by 0.00%.
Over the last 4 quarters, Edgewise Therapeutics has averaged an EPS surprise of 0.09% and a revenue surprise of 0.00%.
Earnings Date
Aug 6
EPS Estimate
$-0.480
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Edgewise Therapeutics Earnings History
Analyze the earnings history of Edgewise Therapeutics using advanced sorting and filters.
Loading calendar...
Edgewise Therapeutics (EWTX) Earnings Per Share
The chart below shows Edgewise Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Edgewise Therapeutics (EWTX) Revenue
The chart below shows Edgewise Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Edgewise Therapeutics (NASDAQ:EWTX) reporting earnings?
Edgewise Therapeutics (EWTX) is scheduled to report earnings on August 6, 2026. The last reported earnings were for reported on May 7, 2026 for Q1.
What were the latest earnings per share (EPS) for Edgewise Therapeutics (NASDAQ:EWTX)?
The Actual EPS was $-0.46, which beat the estimate of $-0.49.
What were Edgewise Therapeutics’s (NASDAQ:EWTX) revenues?
The Actual Revenue was $0, which hit the estimate of $0.
